Physician and patient preferences for dosing options in migraine prevention by Robert Cowan, Joshua M. Cohen, Erik Rosenman, Ravi Iyer

Get full text

State and institutional policies on in-state resident tuition and financial aid for undocumented students: Examining constraints and opportunities by Gabriel R. Serna, Joshua M. Cohen, David H. K. Nguyen

Get full text

Methamphetamine use and adoption of preventive behaviors early in the COVID-19 pandemic among men who have sex with men in Los Angeles, California by Joshua M. Cohen, Michael J. Li, Marjan Javanbakht, Pamina M. Gorbach, Steven J. Shoptaw

Get full text

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study by Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio, Ronghua Yang, Sait Ashina, Zaza Katsarava

Get full text

Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies by Peter McAllister, Joshua M. Cohen, Verena Ramirez Campos, Xiaoping Ning, Lindsay Janka, Steve Barash

Get full text

A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States by Lynda J. Krasenbaum, Vasantha L. Pedarla, Stephen F. Thompson, Krishna Tangirala, Joshua M. Cohen, Maurice T. Driessen

Get full text

Effective Treatment of Platysma Bands with Neurotoxin by Rod J. Rohrich, MD, Ira L. Savetsky, MD, Joshua M. Cohen, MD, Yash J. Avashia, MD

Get full text

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlle... by Egilius L. H. Spierings, Mikko Kärppä, Xiaoping Ning, Joshua M. Cohen, Verena Ramirez Campos, Ronghua Yang, Uwe Reuter

Get full text

Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments by George R. Nissan, Richard Kim, Joshua M. Cohen, Michael J. Seminerio, Lynda J. Krasenbaum, Karen Carr, Vincent Martin

Get full text

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study by Dawn C. Buse, Sanjay K. Gandhi, Joshua M. Cohen, Verena Ramirez-Campos, Blaine Cloud, Ronghua Yang, Robert P. Cowan

Get full text

Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials by Stephen D. Silberstein, Joshua M. Cohen, Ronghua Yang, Sanjay K. Gandhi, Evelyn Du, Adelene E. Jann, Michael J. Marmura

Get full text

Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 m... by Messoud Ashina, Joshua M. Cohen, Maja Galic, Verena Ramirez Campos, Steve Barash, Xiaoping Ning, Yoel Kessler, Lindsay Janka, Hans-Christoph Diener

Get full text

Abstract: Is the Medial Sural Artery Perforator Flap A New Workhorse Flap? A Systematic Review and Meta-Analysis by Salma A. Abdou, BA, David A. Daar, MD, MBA, Joshua M. Cohen, BS, Stelios C. Wilson, MD, Jamie P. Levine, MD

Get full text

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study by Antoinette MaassenVanDenBrink, Gisela M. Terwindt, Joshua M. Cohen, Steve Barash, Verena Ramirez Campos, Maja Galic, Xiaoping Ning, Mikko Kärppä

Get full text

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States by Peter McAllister, Lois Lamerato, Lynda J. Krasenbaum, Joshua M. Cohen, Krishna Tangirala, Stephen Thompson, Maurice Driessen, Julian Casciano, Zenobia Dotiwala, Alexander Mauskop

Get full text

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, pla... by Stephanie J. Nahas, Steffen Naegel, Joshua M. Cohen, Xiaoping Ning, Lindsay Janka, Verena Ramirez Campos, Lynda J. Krasenbaum, Dagny Holle-Lee, David Kudrow, Christian Lampl

Get full text

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-control... by Stephanie J. Nahas, Steffen Naegel, Joshua M. Cohen, Xiaoping Ning, Lindsay Janka, Verena Ramirez Campos, Lynda J. Krasenbaum, Dagny Holle-Lee, David Kudrow, Christian Lampl

Get full text

Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study by Maurice T. Driessen, Joshua M. Cohen, Oscar Patterson-Lomba, Stephen F. Thompson, Michael Seminerio, Karen Carr, Todor I. Totev, Rochelle Sun, Erica Yim, Fan Mu, Rajeev Ayyagari

Get full text

Preauthorization Inconsistencies Prevail in Reduction Mammaplasty by Carter J. Boyd, MD, MBA, Kshipra Hemal, MD, Joshua M. Cohen, MD, David A. Daar, MD, MBA, John Gwin, BA, Karen Zupko, BA, Nolan S. Karp, MD

Get full text

Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine by Maurice T. Driessen, Joshua M. Cohen, Stephen F. Thompson, Oscar Patterson-Lomba, Michael J. Seminerio, Karen Carr, Todor I. Totev, Rochelle Sun, Erica Yim, Fan Mu, Rajeev Ayyagari

Get full text